OLMA reported a director's departure and appointed another director to both committees. The filing says there was no disagreement, so this change alone does not point to a different business outlook.
The committee seats remain filled, and the filing gives no sign of a dispute with Olema. It reports no change to the company's plans or business, so this notice alone does not change how Olema looks.
Follow Olema Pharmaceuticals, Inc. (OLMA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for OLMA